Home > Semiconductors & Electronics > Displays > Biophotonics Market

Biophotonics Market Share

Report ID: GMI9733
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Biophotonics Market Share

Thermo Fisher Scientific Inc.hold a significant share of over 6% in the Biophotonics industry. Thermo Fisher Scientific Inc. holds a significant role in the market as a leading provider of innovative technologies and solutions for life sciences and healthcare applications. With a diverse portfolio of products and services, Thermo Fisher Scientific caters to the growing demand for advanced biophotonics tools, including imaging systems, spectroscopy instruments, and analytical technologies.

Carl Zeiss AG.is a key player in the market, renowned for its advanced optical and imaging technologies that enable groundbreaking discoveries in life sciences and healthcare. The company's contributions to biophotonics span a wide range of applications, from high-resolution microscopy systems to sophisticated imaging platforms for biomedical research and clinical diagnostics.

Biophotonics Market Companies

Major players operating in the biophotonics industry are:

Affymetrix Inc. (Thermo Fisher Scientific Inc.)
Becton, Dickinson and Company
Carl Zeiss AG
Glenbrook Technologies
Hamamatsu Photonics K.K
IDEX
IPG Photonics Corporation
NU Skin Enterprises
Olympus Corporation
Oxford Instruments PLC
PerkinElmer Inc.
Thermo Fisher Scientific
TOSHIBA CORPORATION
Zecotek Photonics Inc.
ZEISS Group
Zenalux Biomedical Inc.

Authors: Suraj Gujar, Sandeep Ugale

Frequently Asked Questions (FAQ) :

Industry size for biophotonics was worth more than USD 70.49 billion in 2023 and is projected to expand at over 10.9% CAGR from 2024 to 2032, led by the growing emphasis on personalized medicine and precision agriculture.

The in-vitro technology segment in the biophotonics industry is estimated to grow at over 10% CAGR between 2024 and 2032, due to its wide use in analyzing biological samples outside the living organism.

The see-through imaging segment in the biophotonics industry accounted for over 10% share in 2023, as it allows researchers and clinicians to visualize biological structures and processes within living organisms with unprecedented clarity and depth.

North America market recorded over 36% share in 2023 and is projected to grow CAGR between 2024 and 2032, attributed to the robust technological innovation, extensive research infrastructure, and significant investments in healthcare.